AstraZeneca Covid-19 antibody treatment ‘more effective than vaccines’

Trial finds injection reduces risk of symptomatic infection by 83%

A Covid-19 treatment derived from the immune cells of virus survivors gives better protection than vaccines after six months and could last for a year, a trial has found.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up